Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjogren's syndrome

被引:14
作者
Saegusa, K
Ishimaru, N
Yanagi, K
Haneji, N
Nishino, M
Azuma, M
Saito, I
Hayashi, Y
机构
[1] Univ Tokushima, Sch Dent, Dept Pathol, Tokushima 770, Japan
[2] Univ Tokushima, Sch Dent, Dept Pediat Dent, Tokushima 770, Japan
[3] Natl Childrens Med Res Ctr, Dept Immunol, Tokyo 154, Japan
关键词
D O I
10.4049/jimmunol.165.4.2251
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Organ-specific autoimmune exocrinopathy resembling Sjogren's syndrome (SS) that spontaneously develops in NFS/sld mutant mice thymectomized 3 day after birth is dependent on Th1-type CD4(+) T cells, We previously reported that a cleavage product of 120-kDa alpha-fodrin may be an important autoantigen in the pathogenesis of SS in both an animal model and the patients. We demonstrate that in an animal model of SS with overt exocrinopathy, a unique CD4(+) T cell subset expressing CD28(low) is dramatically increased in spleen cells before the disease onset, but that the CD4(+) T cells of diseased mice were virtually all CD28(high). We found that the spleen cells in these mice before the disease onset showed a significant increase in autoantigen-specific T cell proliferation. Analysis of in vitro cytokine production by spleen cells indicated, before the disease onset, severely impaired production of IL-2 and IFN-gamma in the animal model, whereas high levels of IL-4 were observed. Expression of cytokine genes, including IL-4, IL-10, and TGF-beta, was detected in FACS-sorted CD4(+)CD28(low) T cells by RT-PCR analysis. Transfer of CD4(+)CD28(low) T cells into the animal model actually prevented the development of autoimmune lesions including autoantibody production. These results suggest that a CD4(+)CD28(low) T cell subset that is continuously activated by an organ-specific autoantigen may play a regulatory role in the development of organ-specific autoimmune disease in an animal model of SS.
引用
收藏
页码:2251 / 2257
页数:7
相关论文
共 47 条
[1]  
AHUJA SS, 1993, J IMMUNOL, V150, P3109
[2]   PEPTIDE-INDUCED T-CELL TOLERANCE TO PREVENT AUTOIMMUNE DIABETES IN A TRANSGENIC MOUSE MODEL [J].
AICHELE, P ;
KYBURZ, D ;
OHASHI, PS ;
ODERMATT, B ;
ZINKERNAGEL, RM ;
HENGARTNER, H ;
PIRCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :444-448
[3]   T-CELL PRIMING VERSUS T-CELL TOLERANCE INDUCED BY SYNTHETIC PEPTIDES [J].
AICHELE, P ;
BRDUSCHARIEM, K ;
ZINKERNAGEL, RM ;
HENGARTNER, H ;
PIRCHER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :261-266
[4]   A range of CD4 T cell tolerance: Partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis [J].
Akkaraju, S ;
Ho, WY ;
Leong, D ;
Canaan, K ;
Davis, MM ;
Goodnow, CC .
IMMUNITY, 1997, 7 (02) :255-271
[5]   MOLECULAR-CLONING OF A CD28 CDNA BY A HIGH-EFFICIENCY COS CELL EXPRESSION SYSTEM [J].
ARUFFO, A ;
SEED, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8573-8577
[6]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[7]   FUNCTIONAL EXPRESSION OF B7/BB1 ON ACTIVATED LYMPHOCYTES-T [J].
AZUMA, M ;
YSSEL, H ;
PHILLIPS, JH ;
SPITS, H ;
LANIER, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :845-850
[8]   T-CELL-MEDIATED INHIBITION OF THE TRANSFER OF AUTOIMMUNE DIABETES IN NOD MICE [J].
BOITARD, C ;
YASUNAMI, R ;
DARDENNE, M ;
BACH, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1669-1680
[9]   THE 2-SIGNAL MODEL OF LYMPHOCYTE-ACTIVATION 21 YEARS LATER [J].
BRETSCHER, P .
IMMUNOLOGY TODAY, 1992, 13 (02) :74-76
[10]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211